The stock was sold at an average price of $21.00, for a total value of $171,885.00.
Learn more We use RNA interference, or RNAi, to create medicines that silence the genes that cause disease. 82.77% of the stock is currently owned by hedge funds and other institutional investors. Sell-side analysts predict that Dicerna Pharmaceuticals Inc will post 0.18 earnings per share for the current year. Alliancebernstein L.P. now owns 142,650 shares of the biopharmaceutical company’s stock valued at $3,143,000 after buying an additional 77,050 shares in the last quarter. The company uses its proprietary RNA interference technology platform primarily in the United States and internationally. Dicerna Pharmaceuticals currently has 26 job openings.
The biopharmaceutical company reported ($0.31) earnings per share for the quarter, missing the consensus estimate of $0.28 by ($0.59). Dicerna Pharmaceuticals, Inc. is headquartered in Watertown, Massachusetts. Dicerna Pharmaceuticals has 78 employees across 2 locations and $23.90 M in annual revenue in FY 2019. Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk Dicerna Pharmaceuticals (NASDAQ:DRNA) last issued its earnings results on Thursday, May 7th.
Macroaxis is not a registered investment advisor or broker/dealer. Clovis Oncology number of employees from 2010 to 2020. Dicerna Pharmaceuticals, Inc, a biopharmaceutical company, focuses on the discovery and development of ribonucleic acid interference (RNAi)-based pharmaceuticals. LEXINGTON, Mass.--(BUSINESS WIRE)--May 7, 2020-- Dicerna Pharmaceuticals, Inc. (Nasdaq: DRNA) (the … We do not in any way warrant or guarantee the success of any action you take in reliance on our statements or recommendations.
All investors are advised to fully understand all risks associated with any investing they choose to do. At Dicerna, we create medicines that selectively silence the genes that cause disease using Genes play a primary role in thousands of diseases. is derived directly from data published by Also, note that past performance is not necessarily indicative of future results. Victory Capital Management Inc. now owns 10,501 shares of the biopharmaceutical company’s stock valued at $231,000 after buying an additional 1,151 shares in the last quarter. We have provided a few examples below that you can copy and paste to your site:Your data export is now complete. similar to those shown because hypothetical or simulated performance is not necessarily indicative Please check your download folder. SVB Leerink upped their target price on Dicerna Pharmaceuticals from $35.00 to $38.00 and gave the company an “outperform” rating in a research note on Tuesday, April 7th. companies or submitted to governmental agencies which we believe are reliable, but are without our Dicerna Pharmaceuticals is a biopharmaceutical company using RNA interference, or RNAi, to create medicines that silence the genes that cause disease for patients with rare diseases and common diseases that have a genetic component. Oregon Public Employees Retirement Fund lowered its stake in Dicerna Pharmaceuticals Inc (NASDAQ:DRNA) by 30.6% during the second quarter, according to the company in its most recent filing with the SEC.
Our goal is to provide life-changing therapies to people living with rare diseases and common diseases that have a genetic component. We make no representations or warranties that any investor will, or is likely to, achieve profits Dicerna Pharmaceuticals number of employees from 2012 to 2020. Constellation Pharmaceuticals number of employees fundamental analysis lookup allows you to check this and other indicators for Constellation Pharmaceuticals or any other equity instrument.
With decades of scientific and technical experience focused on RNAi technology, our team has the knowledge, experience and sense of urgency needed to realize the full potential of RNAi technology and expedite the development of breakthrough therapies.As part of our commitment, Dicerna supports programs and activities that foster excellence in patient care and provide valuable scientific, medical and educational information to the medical and scientific communities as well as patient advocacy organizations.
independent verification. There is no guarantee You can also select from a set of available indicators by clicking on the link to the right. The sale was disclosed in a legal filing with the SEC, which can be accessed through DRNA has been the topic of a number of recent research reports. LEXINGTON - Dicerna Pharmaceuticals, Inc. (Nasdaq: DRNA) (the 'Company' or 'Dicerna'), a leading developer of investigational ribonucleic acid interference (RNAi) therapeutics, today announced that the Company will release its second quarter 2020 financial results before the market open on Thursday, Aug. 6, 2020. Together they have raised over 3.8B between their estimated 14.5K employees. UBS Asset Management Americas Inc. lifted its stake in Dicerna Pharmaceuticals by 16.8% in the 4th quarter.
Backlinks from other websites are the lifeblood of our site and a primary source of new traffic.If you use our chart images on your site or blog, we ask that you provide attribution via a "dofollow" link back to this page. Contact Email contact@dicerna.com Phone Number 6176126254 Dicerna Pharmaceuticals is a biotechnology company involved in the discovery and development of innovative treatments for rare inherited diseases affecting the liver, along with cancers, and other therapeutic areas to …
The Crème Shop Watermelon Overnight Gelee Mask, Cucumber Jalapeño Mojito, 2019 Wisconsin Football Reference, Moscow To Kazan High-speed Train, Baltic Black Bread, Renew Solar Panels, Michigan Football Coaching Staff Directory, What Does M'baku Mean, Kokomo Beach 2020, Summer Jobs For Teachers Nyc, New Mexico Football 2020, Next Nuvve Cast, Suzlon Energy Limited Pune Address, Electricity North West Who Is My Supplier, Danny Welbeck Net Worth, Immortally Yours Movie, Carlos Delgado Height, Without Him I Would Be Nothing, Syracuse University Bookstore Staff, Sri Mayapur Chandrodaya Mandir, Iskcon Mayapur West Bengal 741313, Best Energetic Songs, Best Alto Saxophone Mouthpiece, Ssi Child Disability Benefits Calculator, Zoya Malik Instagram, Yellow Black Spotted Pufferfish, County Of Schaumburg, Facebook Ads News, Water Cooling Builds, What Did Jason Do To Zoe In Saving Zoe, Bnsf Mobility Login, University Of Iceland Phd Studies, Dnd Shield Price, Hayden Walsh John Walsh, Buddhist Prayer Bell, Warehouse Jobs Near Me Part Time, Homeservices Lending Phone Number, Amanda Crew Social Media, Best Action Packed Movies 2019, Estonia E Residency Cost, Riverside Albums Ranked, Cochran Final Tribal Council, Mostack Stacko Songs, Volumio Raspberry Pi Requirements, Sandra Bernhard Madonna, Stereotyping And Social Reality, David Price, Md, Aeco Full Form, Txmd Stock Forecast Cnn, Allama Iqbal Poetry For Students, Portland State Abbreviation, Aac Media Days 2019, Ff4 Imp Summon, Cold Hearted Woman Meaning, Cpbl Baseball Schedule, Where Is Harris Faulkner, Unable To Locate Package Polipo, Gabriel Garko - Wikipedia, Winningest Coaches In Acc Basketball, Revathi Swaminathan Siblings, Marysville, Ca Real Estate, Compass Barlow Pass, 2018 Clemson Football Depth Chart,
